Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Dow
AstraZeneca
Medtronic
Express Scripts
Moodys
Harvard Business School

Last Updated: January 21, 2020

DrugPatentWatch Database Preview

HYDROXYZINE PAMOATE Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Hydroxyzine Pamoate, and when can generic versions of Hydroxyzine Pamoate launch?

Hydroxyzine Pamoate is a drug marketed by Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, and Watson Labs. and is included in thirty-four NDAs.

The generic ingredient in HYDROXYZINE PAMOATE is hydroxyzine pamoate. There are nineteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the hydroxyzine pamoate profile page.

US ANDA Litigation and Generic Entry Outlook for Hydroxyzine Pamoate

  Start Trial

A generic version of HYDROXYZINE PAMOATE was approved as hydroxyzine pamoate by SANDOZ on January 21st, 2020.

Drug patent expirations by year for HYDROXYZINE PAMOATE
Drug Prices for HYDROXYZINE PAMOATE

See drug prices for HYDROXYZINE PAMOATE

Drug Sales Revenue Trends for HYDROXYZINE PAMOATE

See drug sales revenues for HYDROXYZINE PAMOATE

Recent Clinical Trials for HYDROXYZINE PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shalvata Mental Health CenterN/A

See all HYDROXYZINE PAMOATE clinical trials

Pharmacology for HYDROXYZINE PAMOATE
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists
Synonyms for HYDROXYZINE PAMOATE
(+-)-2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
1-(p-chloro-|A-phenylbenzyl)-4-(2-hydroxyethoxyethyl)piperazine, pamoate
10246-75-0
2-(2-(4-(p-Chloro-alpha-phenylbenzyl)-1-piperazinyl)ethoxy)ethanol 4,4'-methylenebis(3-hydroxy-2-naphthoate) (1:1)
2-naphthoic acid, 4,4'-methylenebis[3-hydroxy-, hydroxyzine salt (6ci)
4-[(3-carboxy-2-hydroxy-1-naphthyl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4-[(3-Carboxy-2-hydroxy-naphthalen-1-yl)methyl]-3-hydroxy-naphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]ethanol
4-[(3-carboxy-2-hydroxynaphthalen-1-yl)methyl]-3-hydroxynaphthalene-2-carboxylic acid; 2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]ethanol
AC1L18EU
AKOS015914218
Atarax P
Atarax-P (TN)
Bobsule
BSPBio_002166
C23H16O6.C21H27ClN2O2
CCG-40218
CHEMBL1200467
CTK0H5141
D01096
DivK1c_000503
EBD55260
EINECS 233-582-1
Equipose
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, (+-)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
Ethanol, 2-(2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-, compd. with 4,4'-methylenebis(3-hydroxy-2-naphthalenecarboxylic acid) (1:1)
FT-0697190
HMS1920F11
HMS2091L19
HMS2235O19
HMS501J05
HY-B0895
Hy-Pam
HY-PAM "25"
Hydroxyzine (pamoate)
Hydroxyzine embonate
Hydroxyzine pamoate (JP17/USP)
Hydroxyzine pamoate [USAN:JAN]
Hydroxyzine pamoate [USP:JAN]
Hydroxyzine pamoate salt
Hydroxyzine pamoate salt, analytical standard
Hydroxyzine pamoate, United States Pharmacopeia (USP) Reference Standard
hydroxyzinepamoate,usp
Hydroxyzyne pamoate
HYYDROXYZINE PAMOATE
I14-44826
IDI1_000503
J-000695
KBio1_000503
KBio2_001391
KBio2_003959
KBio2_006527
KBio3_001386
KBioGR_000385
KBioSS_001391
LS-171818
Masmoran
MLS000028605
MolPort-003-666-206
NCGC00021152-02
NCGC00021152-03
NCGC00094698-01
NCGC00094698-02
NINDS_000503
NSC-757063
NSC757063
Paxisitil
Pharmakon1600-01500345
SBI-0051413.P003
SCHEMBL41333
SMR000058728
SPBio_001099
Spectrum_000911
SPECTRUM1500345
Spectrum2_001000
Spectrum3_000463
Spectrum4_000013
Spectrum5_000838
SR-01000003149
SR-01000003149-2
SR-01000003149-4
Vistaril pamoate (TN)

US Patents and Regulatory Information for HYDROXYZINE PAMOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086705-001 Jul 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 081165-001 Jul 31, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087767-001 Aug 16, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 086698-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088496-001 Jun 15, 1984 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Moodys
Johnson and Johnson
Dow
Merck
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.